Integrative Cancer Symptom Management: Evidence-Based Guide to Fatigue, Pain, Nausea, Neuropathy, Sleep & Palliative Care (2026)

November 13, 2026

SmartCancer | OneDayMD Integrative Oncology Research

Last updated: November 2026

Cancer treatment is not measured only by tumor response, remission or survival. How patients feel, function, sleep, eat and live during treatment matters too.

Fatigue, pain, nausea, vomiting, peripheral neuropathy, insomnia, hot flashes and gastrointestinal problems can substantially affect quality of life. Some symptoms are caused by the cancer itself, others by surgery, chemotherapy, radiotherapy, immunotherapy, hormonal treatment or supportive medications.

Many of these problems can be prevented, reduced or managed through appropriate medical treatment and supportive care. Selected complementary approaches, including acupuncture, mindfulness, relaxation, massage and other mind–body interventions, may provide additional benefits in specific clinical situations.

This SmartCancer guide brings these approaches together in one evidence-based resource. We examine what causes common cancer-related symptoms, how they are assessed, which treatments have established clinical support, where integrative approaches may help and when symptoms require urgent medical attention.

Our principle: Treat the symptom, identify its cause, protect the patient and preserve quality of life without compromising cancer treatment.

Important clinical distinction

Integrative symptom management is part of comprehensive supportive oncology. It is not alternative cancer treatment.

Complementary therapies may be used alongside appropriate medical treatment where evidence, safety and patient circumstances support their use.

They should not delay treatment of serious complications or replace prescribed antiemetics, analgesics, neuropathy management, psychological care or palliative care.

Explore the Symptom Management Hub

01. Cancer-Related Fatigue

Persistent exhaustion, reduced energy, physical deconditioning and fatigue management.

Explore fatigue management →

02. Cancer Pain

Tumor-related pain, treatment-related pain, neuropathic pain and integrative pain management.

Explore cancer pain →

03. Nausea and Vomiting

Chemotherapy-induced nausea, delayed vomiting, anticipatory nausea and supportive approaches.

Explore nausea management →

04. Peripheral Neuropathy

Numbness, tingling, burning pain, balance problems and chemotherapy-induced nerve injury.

Explore neuropathy →

05. Sleep Disturbance

Insomnia, interrupted sleep, sleep anxiety, circadian disruption and CBT for insomnia.

Explore sleep management →

06. Hot Flashes and Night Sweats

Menopausal symptoms, hormonal treatment effects and nonhormonal management.

Explore vasomotor symptoms →

07. Gastrointestinal Symptoms

Diarrhea, constipation, mucositis, appetite changes, taste problems and swallowing difficulties.

Explore gastrointestinal care →

08. Palliative and Supportive Care

Symptom relief, psychological support, communication, caregiver support and quality of life.

Explore palliative care →

Contents

What is integrative cancer symptom management?
The principles of comprehensive symptom care
Symptom assessment and monitoring
Cancer-related fatigue
Cancer pain and integrative pain management
Nausea and vomiting
Chemotherapy-induced peripheral neuropathy
Sleep disturbance and insomnia
Hot flashes and night sweats
Gastrointestinal symptoms and oral complications
Anxiety, depression and psychological distress
Palliative care and advanced cancer
Complementary therapies: evidence and limitations
When to seek urgent medical attention
The integrated symptom management pathway
Frequently asked questions
Guidelines and research library

1. What Is Integrative Cancer Symptom Management?

Integrative cancer symptom management is a patient-centred approach that combines established medical treatment with evidence-informed supportive and complementary interventions to reduce the physical, psychological and functional burden of cancer.

It recognizes that cancer symptoms can arise from different causes and may require different interventions.

For example, fatigue may result from anemia, treatment toxicity, inflammation, poor sleep, depression or muscle loss. Treating the fatigue without identifying its underlying cause may leave the patient with an incomplete response.

Three complementary components

1. Medical Symptom Treatment

Medication, procedures, rehabilitation, clinical investigations and treatment of the underlying cause.

2. Supportive Oncology

Nutrition, hydration, exercise, sleep support, psychological care and symptom monitoring.

3. Evidence-Based Complementary Care

Selected approaches such as acupuncture, mindfulness, CBT, hypnosis, massage and adapted movement therapies.

These approaches should be coordinated rather than delivered as disconnected treatments. A patient experiencing chemotherapy-related nausea, for example, needs appropriate antiemetic medication as well as nutritional advice and practical symptom support.

What is the difference between supportive, palliative and integrative care?

Approach	Main purpose	When it is used
Supportive care	Prevent and manage symptoms and complications of cancer and its treatment.	Throughout the cancer journey.
Palliative care	Relieve suffering and improve quality of life across physical, psychological, social and spiritual dimensions.	At any stage where palliative needs exist; particularly important in advanced cancer.
Integrative oncology	Combine conventional cancer care with selected evidence-informed complementary interventions.	Before, during and after cancer treatment.
Hospice care	Provide comfort-focused care when the goals and circumstances meet the relevant hospice eligibility framework.	Generally towards the end of life, depending on jurisdiction and clinical circumstances.

Palliative care and active cancer treatment are not mutually exclusive. Patients can receive chemotherapy, immunotherapy or targeted therapy while also receiving specialist palliative care.

2. The Principles of Comprehensive Symptom Care

Effective symptom management should be systematic, individualized and responsive to changes in the patient's condition.

Five guiding principles

Identify the cause. Do not assume every symptom is simply a side effect of cancer treatment.
Prioritize evidence-based treatment. Use established medical interventions where indicated.
Consider the whole patient. Include nutrition, physical function, sleep, mental health and social circumstances.
Integrate complementary approaches selectively. Use therapies according to their evidence and safety for the specific symptom.
Monitor outcomes. Assess symptom severity, daily functioning, adverse effects and response to treatment.

Symptoms can have multiple causes

A patient receiving chemotherapy may experience fatigue due to anemia, pain, sleep disturbance, medication effects and physical deconditioning simultaneously.

Addressing only one factor may not be sufficient.

The most effective approach often combines appropriate investigation, medical symptom control, physical rehabilitation, nutritional support and psychological care.

3. Symptom Assessment: What Should Be Measured?

Symptom management should begin with a clear assessment of what the patient is experiencing, how severe it is, how long it has persisted and how it affects daily life.

Useful assessment domains

Assessment	What to record	Clinical purpose
Symptom intensity	Severity, frequency, duration and pattern.	Establish a baseline and evaluate response.
Functional impact	Ability to walk, eat, sleep, work and perform everyday activities.	Identify effects on independence and quality of life.
Treatment relationship	Relationship with chemotherapy cycles, radiotherapy, hormonal therapy or surgery.	Identify potentially treatment-related causes.
Medication review	Prescription drugs, supplements and non-prescription products.	Identify adverse effects and interactions.
Physical assessment	Neurological function, hydration, mobility and relevant examination findings.	Identify complications requiring treatment.
Psychological assessment	Anxiety, depression, distress and coping difficulties.	Recognize psychological factors contributing to symptoms.
Patient-reported outcomes	Symptom scores and quality-of-life measures.	Monitor changes over time.

Validated symptom assessment tools

Depending on the clinical situation, professionals may use:

Edmonton Symptom Assessment System (ESAS).
Brief Pain Inventory (BPI).
Brief Fatigue Inventory (BFI).
FACIT-Fatigue questionnaire.
Insomnia Severity Index (ISI).
Hospital Anxiety and Depression Scale (HADS).
Patient-reported outcome measures such as PRO-CTCAE.

These tools can help identify changes that might otherwise be missed during short clinical consultations.

The goal is not simply to reduce a symptom score.

Successful symptom management should also help patients eat, sleep, move, function, communicate and participate in daily life as comfortably as possible.

4. Cancer-Related Fatigue: Persistent Exhaustion and Reduced Function

Cancer-related fatigue is one of the most common and disruptive symptoms experienced by people with cancer.

It is characterized by persistent physical, emotional or cognitive exhaustion that is disproportionate to recent activity and interferes with usual functioning.

Unlike ordinary tiredness, cancer-related fatigue may not resolve with a good night's sleep or a period of rest.

What causes cancer-related fatigue?

Cancer-related inflammation and metabolic changes.
Chemotherapy and radiotherapy.
Anemia and other blood-related abnormalities.
Poor sleep or insomnia.
Pain and medication adverse effects.
Depression, anxiety and psychological distress.
Endocrine abnormalities, including thyroid dysfunction.
Inadequate nutrition, dehydration and muscle loss.
Physical deconditioning.
Progressive disease or infection.

Because multiple mechanisms may coexist, fatigue should not automatically be attributed to the cancer or chemotherapy without appropriate assessment.

Evidence-based interventions

The 2024 joint ASCO–Society for Integrative Oncology guideline reviewed 113 randomized controlled trials and provides recommendations for managing fatigue during and after cancer treatment.

Intervention	During treatment	After treatment
Exercise	Recommended	Recommended
Cognitive behavioral therapy	Recommended	Recommended
Mindfulness-based programs	Recommended	Recommended
Tai chi or qigong	Recommended at low to moderate intensity	Insufficient evidence for a general recommendation for fatigue in survivors
Psychoeducation	May be recommended	Evidence varies
Yoga	Not a general recommendation during treatment for fatigue	May be recommended for selected survivors
Acupressure	Insufficient evidence for a general recommendation	May be considered

The guideline also found that American ginseng may help selected patients during treatment, but the evidence was low quality and the recommendation conditional. Supplement selection, medication interactions and suitability require clinical review.

It did not support routine use of L-carnitine, antidepressants or wakefulness agents as treatments for cancer-related fatigue.

ASCO–SIO: Management of Fatigue in Adult Survivors of Cancer (2024) →

Practical fatigue management

Investigate potentially reversible causes.
Use individualized aerobic and resistance exercise.
Consider CBT and mindfulness-based interventions.
Address insomnia and nighttime symptoms.
Optimize nutritional intake and hydration.
Manage pain and medication adverse effects.
Balance activity with planned recovery periods.

When fatigue needs urgent assessment

Sudden or rapidly worsening fatigue may signal anemia, bleeding, infection, dehydration, heart or lung complications, metabolic abnormalities or disease progression.

New breathlessness, chest pain, fainting, confusion or fever should not be dismissed as ordinary cancer fatigue.

5. Cancer Pain: Medical Treatment and Integrative Pain Management

Cancer pain can arise from the tumor itself, metastases, surgery, radiotherapy, chemotherapy, inflammation or damage to nerves and surrounding tissue.

It is one of the most important symptoms to address because persistent uncontrolled pain can interfere with sleep, mobility, appetite, mood and quality of life.

Types of cancer pain

Pain type	Common characteristics	Possible causes
Nociceptive pain	Aching, pressure or localized pain.	Tumor-related tissue injury, bone involvement or inflammation.
Neuropathic pain	Burning, tingling, electric shocks or shooting pain.	Nerve compression, nerve injury or chemotherapy-induced neuropathy.
Procedural pain	Pain associated with an examination or medical intervention.	Biopsies, surgery, injections and other procedures.
Treatment-related pain	May be acute or persistent.	Surgery, radiotherapy, chemotherapy and hormonal therapy.
Musculoskeletal pain	Joint, muscle or movement-related discomfort.	Deconditioning, treatment effects, immobility or medication-related arthralgia.

Standard medical pain management

Pain treatment should be tailored to intensity, cause, duration, functional impact and patient circumstances.

Options may include:

Paracetamol or selected anti-inflammatory medicines where appropriate.
Opioid analgesics for moderate-to-severe cancer pain when indicated.
Medicines targeting specific neuropathic pain mechanisms.
Radiotherapy for painful bone metastases in appropriate settings.
Nerve blocks and other interventional pain procedures.
Management of the underlying cancer when appropriate.
Rehabilitation and physical therapy.

The 2023 ASCO guideline recommends offering opioids to adults with moderate-to-severe cancer pain unless contraindicated. It also emphasizes shared decisions, individualized treatment goals, dose monitoring and prevention of adverse effects.

Appropriately prescribed opioids are an important component of cancer pain treatment. Patients should not avoid discussing them simply because of stigma surrounding opioid medicines.

ASCO: Use of Opioids for Adults With Pain From Cancer or Cancer Treatment (2023) →

Integrative approaches for cancer pain

The 2022 Society for Integrative Oncology–ASCO guideline evaluated 198 randomized controlled trials and 26 systematic reviews and meta-analyses.

Complementary intervention	Specific clinical context	Guideline interpretation
Acupuncture	Aromatase inhibitor-related joint pain.	Recommended in the defined setting.
Acupuncture	Selected general cancer pain and musculoskeletal pain.	May be offered.
Reflexology or acupressure	Selected general cancer pain and musculoskeletal pain.	May be offered.
Hypnosis	Pain during cancer-related procedures.	May be offered.
Massage	Pain in palliative or hospice care.	May be offered by appropriately qualified practitioners.

Evidence for many other complementary products and natural treatments remains low or inconclusive.

Massage should be modified or avoided over vulnerable areas such as tumor sites, recent surgical wounds, fragile bones, thrombosis or areas of significant lymphedema unless specifically cleared by the care team.

SIO–ASCO: Integrative Medicine for Pain Management in Oncology →

Pain assessment: what patients should report

Location and nature of pain.
Severity and frequency.
What makes it worse or better.
Whether pain interrupts sleep.
Effect on walking, eating and normal activity.
Response and side effects from medication.
Any new weakness, numbness or neurological symptoms.

Persistent or worsening pain warrants reassessment. Pain should not be treated as an inevitable part of living with cancer.

6. Cancer-Related Nausea and Vomiting

Nausea and vomiting are common complications of cancer and its treatment. They can affect food intake, hydration, medication adherence and quality of life.

They may be caused by chemotherapy, radiotherapy, immunotherapy, other medicines, gastrointestinal problems or the cancer itself.

Different forms of treatment-related nausea

Acute: Occurs within the first 24 hours after chemotherapy.
Delayed: Develops more than 24 hours after chemotherapy and may persist for several days.
Anticipatory: Occurs before treatment, often associated with previous unpleasant experiences.
Breakthrough: Occurs despite preventive antiemetic medication.
Refractory: Persists despite attempts to manage symptoms in previous treatment cycles.

Standard antiemetic treatment

Modern oncology uses risk-based antiemetic prevention. The medicines selected depend on the emetogenic risk of the specific chemotherapy regimen and individual patient risk factors.

Common antiemetic classes include:

Medicine class	Example	Role
5-HT3 receptor antagonists	Ondansetron, granisetron, palonosetron.	Block serotonin-related nausea pathways.
NK1 receptor antagonists	Aprepitant and related medicines.	Help prevent acute and delayed chemotherapy-induced vomiting.
Corticosteroids	Dexamethasone.	Used in selected preventive antiemetic combinations.
Antipsychotic antiemetic	Olanzapine.	Included in selected high-emetic-risk preventive regimens and used in some breakthrough settings.
Dopamine receptor antagonists	Metoclopramide and selected alternatives.	Used for selected nausea and vomiting indications.

For highly emetogenic chemotherapy, MASCC–ESMO guidance recommends a combination of different antiemetic classes, including a 5-HT3 antagonist, an NK1 antagonist, dexamethasone and olanzapine in appropriate settings.

The exact regimen, dosing and duration depend on chemotherapy type and current clinical protocols. Patients should follow their prescribed antiemetic plan rather than constructing combinations independently.

2023 MASCC–ESMO Guideline: Prevention of Chemotherapy- and Radiotherapy-Induced Nausea and Vomiting →

Integrative approaches to nausea

Some non-pharmacological interventions have been investigated as additional supportive approaches.

Acupressure, including wrist-based P6 approaches.
Selected acupuncture interventions.
Relaxation and controlled breathing.
Psychological approaches for anticipatory nausea.
Dietary adjustments for smell, taste and food tolerance.

Evidence varies by intervention and treatment setting. Complementary approaches must not replace guideline-based antiemetic prevention.

Practical nutritional measures

Eat small, frequent meals if tolerated.
Choose foods with mild odors.
Drink fluids in small amounts throughout the day if large amounts worsen nausea.
Identify food textures and smells that trigger symptoms.
Use prescribed antiemetics according to the treatment plan.
Seek nutritional advice if intake is becoming inadequate.

When nausea needs further investigation

Persistent nausea may not be due to chemotherapy alone. Other causes include constipation, bowel obstruction, dehydration, metabolic abnormalities, medication effects, infection or central nervous system involvement.

Repeated vomiting, inability to retain fluids, reduced urine output, abdominal swelling or severe abdominal pain requires prompt medical assessment.

NCI: Nausea and Vomiting During Cancer Treatment →

7. Chemotherapy-Induced Peripheral Neuropathy

Chemotherapy-induced peripheral neuropathy (CIPN) is damage to peripheral nerves associated with certain cancer treatments.

It can affect the hands, feet and sometimes other areas, causing symptoms that range from mild tingling to persistent burning pain, numbness and functional impairment.

Which cancer medicines may cause neuropathy?

Platinum-based chemotherapy, including cisplatin and oxaliplatin.
Taxanes, including paclitaxel and docetaxel.
Vinca alkaloids, including vincristine.
Proteasome inhibitors, including bortezomib.
Selected immunomodulatory cancer medicines.

Symptoms

Tingling or numbness in the fingers and toes.
Burning or electric-shock sensations.
Reduced sensitivity to heat, cold or touch.
Pain or discomfort when walking.
Difficulty handling small objects.
Balance problems and increased falls risk.
Difficulty with buttons, writing and other fine-motor activities.

What should be assessed?

Clinicians should assess symptoms before and during treatment, especially when patients receive neurotoxic chemotherapy.

Assessment includes:

Type and extent of numbness, tingling and pain.
Impact on walking and everyday activities.
Balance and falls.
Fine-motor ability.
Existing diabetes or other neuropathy risk factors.
Potential alternative causes, such as vitamin B12 deficiency or nerve compression.

What does the ASCO guideline recommend?

ASCO's chemotherapy-induced peripheral neuropathy guideline states that no pharmacological agent has sufficient evidence to be routinely recommended for preventing CIPN.

It also discourages acetyl-L-carnitine for CIPN prevention because of evidence suggesting potential harm.

For established painful CIPN, duloxetine is the medication with evidence supporting a clinical recommendation, although the benefit is limited.

Other interventions, including gabapentinoids, acupuncture, exercise therapy and scrambler therapy, have insufficient evidence for a general recommendation as CIPN treatments outside clinical trials.

When neuropathy becomes intolerable or affects function during chemotherapy, the oncology team should evaluate whether treatment delay, dose modification or a change of chemotherapy is appropriate.

ASCO: Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy →

Supportive measures

Balance and functional rehabilitation.
Appropriate footwear and foot protection.
Falls prevention.
Occupational therapy for fine-motor difficulties.
Assessment of pain and sleep disruption.
Medication review and chemotherapy reassessment when necessary.

Do not self-treat neuropathy with high-dose supplements.

Vitamin B products, antioxidants and other supplements are not automatically safe or effective for chemotherapy-induced neuropathy. Some supplements have been investigated and found ineffective for prevention or potentially harmful.

8. Sleep Disturbance and Insomnia in Cancer

Sleep problems are common throughout the cancer journey. Patients may struggle with falling asleep, remaining asleep, waking too early or experiencing unrefreshing sleep.

Insomnia can worsen fatigue, pain sensitivity, emotional distress and daytime functioning.

Why does cancer affect sleep?

Pain and physical discomfort.
Anxiety and uncertainty surrounding diagnosis.
Hot flashes and night sweats.
Corticosteroid medicines.
Hospitalization and treatment schedules.
Frequent urination and gastrointestinal symptoms.
Depression and other mental health conditions.
Altered circadian rhythms.

CBT-I: The preferred first-line approach

Cognitive behavioral therapy for insomnia (CBT-I) is a structured psychological treatment designed to address the habits, thoughts and behaviors that perpetuate insomnia.

It may include:

Stimulus control.
Appropriate sleep scheduling.
Cognitive strategies for sleep-related anxiety.
Relaxation training.
Sleep-related behavioral modification.

The 2023 ESMO Clinical Practice Guideline recommends CBT-I as the standard of care for insomnia in cancer survivors.

Digital CBT-I may be offered when face-to-face programs are unavailable. Brief behavioral therapy for insomnia may be considered for selected patients undergoing active cancer treatment.

Sleep hygiene alone is often insufficient for persistent insomnia, although it remains a useful component of good sleep management.

ESMO: Insomnia in Adult Patients With Cancer (2023) →

Other sleep management approaches

Treat pain and nighttime symptoms.
Review medicines that may interfere with sleep.
Maintain consistent waking times.
Get appropriate daytime light exposure.
Reduce excessive late-day caffeine.
Use relaxation and mindfulness techniques.
Consider specialist sleep assessment when symptoms persist.

Medication and melatonin

Medication may be considered in selected patients after assessment of the cause and potential interactions.

ESMO notes that hypnotic medication may be useful in selected short-term circumstances but that adverse effects and risks associated with prolonged use must be considered.

Melatonin may be considered when circadian disruption is contributing to insomnia and suitable non-pharmacological options are limited. Evidence does not support treating it as a universal sleep remedy or cancer therapy.

9. Hot Flashes and Night Sweats During Cancer Treatment

Hot flashes and night sweats are particularly common in patients receiving treatments that reduce sex hormone levels.

They can occur during breast cancer endocrine therapy, ovarian suppression, menopause-related treatment changes and androgen deprivation therapy for prostate cancer.

Why do they occur?

Changes in estrogen or androgen signaling can affect the hypothalamic thermoregulatory pathways responsible for regulating body temperature.

Patients may experience:

Sudden sensations of intense heat.
Facial and upper-body flushing.
Increased sweating.
Nighttime awakenings.
Interrupted sleep.
Irritability and reduced quality of life.

Non-hormonal supportive interventions

Lightweight clothing and layered bedding.
Cooling fans and a comfortable sleeping environment.
Identifying individual triggers such as alcohol, spicy food or hot environments.
Mindfulness and relaxation.
Cognitive behavioral approaches.
Clinical hypnosis.
Selected acupuncture interventions.
Appropriate physical activity and healthy lifestyle habits.

Non-hormonal medications

Depending on cancer type and treatment, clinicians may consider selected medicines such as:

Some SSRIs or SNRIs.
Gabapentin or pregabalin.
Oxybutynin.
Clonidine in selected circumstances.
Newer neurokinin-pathway agents where appropriate and approved.

Drug choice should account for symptoms, other medications, medical history and the cancer treatment being received.

An important tamoxifen interaction

Tamoxifen is metabolized through CYP2D6 into active metabolites, including endoxifen.

Strong CYP2D6-inhibiting antidepressants, particularly paroxetine and fluoxetine, can reduce endoxifen concentrations and may compromise tamoxifen activation.

Patients taking tamoxifen should not start or stop antidepressants or other medications without reviewing potential interactions with their oncology team or pharmacist.

NCI: Hot Flashes and Night Sweats →

ASCO: Long-Term Follow-Up After Primary Breast Cancer →

Hormone replacement therapy requires special caution.

Systemic hormonal treatment may be unsuitable or contraindicated in hormone-sensitive cancers. Management should be individualized with the oncologist and relevant specialist rather than based on general menopause advice.

10. Gastrointestinal Symptoms and Oral Complications

Gastrointestinal symptoms can develop from the cancer itself, surgery, chemotherapy, radiotherapy, immunotherapy, pain medication and other supportive drugs.

These problems can interfere with hydration, nutrient absorption, appetite, medication adherence and quality of life.

A. Diarrhea

Diarrhea is a common adverse effect of certain chemotherapy regimens, targeted medicines, immunotherapy and radiotherapy involving the abdomen or pelvis.

Its severity ranges from mild loose stools to severe intestinal inflammation, dehydration and electrolyte abnormalities.

Possible causes

Chemotherapy-related intestinal injury.
Immunotherapy-related colitis.
Radiation enteritis.
Infection.
Antibiotic-related changes in gut flora.
Malabsorption or pancreatic insufficiency.
Other prescription medicines and supplements.

General management principles

Inform the oncology team, particularly if diarrhea is new or worsening.
Monitor frequency, volume and duration.
Maintain appropriate fluid and electrolyte replacement.
Review medications and dietary triggers.
Use antidiarrheal medicines only according to the treatment team's instructions.
Investigate persistent or severe symptoms for infection, treatment-related inflammation or other complications.

Immunotherapy warning: New diarrhea in someone receiving an immune checkpoint inhibitor may be immune-related colitis. It should be reported promptly rather than automatically treated as ordinary chemotherapy diarrhea.

B. Constipation

Constipation may be caused by opioid analgesics, antiemetics, reduced movement, dehydration, changes in diet or the cancer itself.

It is particularly important to prevent and manage opioid-induced constipation.

Supportive measures

Appropriate hydration when not medically restricted.
Regular movement within physical capacity.
Individualized dietary fibre intake.
Medication review.
A planned bowel regimen when opioid therapy is prescribed.
Monitoring bowel frequency and stool characteristics.

Patients should not assume that increasing fibre is always appropriate. Suspected obstruction, severe abdominal symptoms, certain gastrointestinal cancers and advanced bowel complications require medical assessment first.

Suppositories and enemas can be unsafe for selected patients, particularly those with low blood counts or bleeding risks. Use only when the treating team recommends them.

NCI: Constipation and Cancer Treatment →

C. Oral Mucositis and Mouth Sores

Oral mucositis is inflammation and ulceration of the lining of the mouth. It can occur following chemotherapy, radiotherapy or certain cancer treatments.

Symptoms may include:

Mouth pain and ulcers.
Difficulty swallowing.
Reduced food and fluid intake.
Bleeding or secondary infection.
Weight loss and nutritional deterioration.

Supportive oral care

Follow an oncology-approved oral hygiene routine.
Use gentle oral cleaning techniques.
Maintain appropriate hydration.
Avoid tobacco and irritating food or oral products.
Use prescribed mouth care treatments.
Seek early treatment for pain and swallowing difficulties.

MASCC/ISOO guidelines support certain interventions in specific clinical settings, including oral cryotherapy for selected chemotherapy regimens and photobiomodulation protocols in defined treatment contexts.

These protocols are not interchangeable or appropriate for every cancer patient. Photobiomodulation should be delivered according to established clinical protocols and by appropriately trained practitioners.

MASCC/ISOO: Mucositis Clinical Practice Guidelines →

D. Taste Changes and Dry Mouth

Changes in taste and reduced saliva production may make food unpleasant or difficult to swallow.

Helpful measures may include:

Experimenting with food temperatures and textures.
Trying alternative protein sources.
Maintaining oral hygiene.
Using saliva substitutes where appropriate.
Managing oral infections and dental problems.
Seeking dietitian advice when food intake decreases.

E. Swallowing Difficulties

Dysphagia may occur with head and neck cancers, esophageal cancers, neurological complications, surgery and radiotherapy.

Swallowing difficulties need proper assessment because of risks of aspiration, dehydration and malnutrition.

Some patients benefit from texture-modified food, swallowing rehabilitation or enteral nutritional support.

F. Appetite Loss and Early Satiety

Poor appetite is common in cancer and may reflect treatment toxicity, inflammation, psychological distress, pain, constipation or cachexia.

Management should address the cause while supporting nutritional intake.

Approaches may include smaller energy-dense meals, oral nutritional supplements, symptom control and assessment for cancer-associated cachexia.

11. Anxiety, Depression and Psychological Distress

Cancer affects more than the body. The diagnosis, uncertainty, treatment burden and fear of progression or recurrence can substantially affect emotional wellbeing.

Anxiety and depression are clinical concerns that deserve proper screening and access to support.

Common psychological symptoms

Persistent worry and fear.
Sleep-related anxiety.
Depressive mood and loss of interest.
Difficulty concentrating.
Fear of recurrence.
Social withdrawal.
Family and financial stress.
Existential or spiritual distress.

Evidence-informed psychological and mind–body approaches

The 2023 Society for Integrative Oncology–ASCO guideline reviewed research on integrative interventions for anxiety and depression in adults with cancer.

Recommendations included the following approaches, with variation according to symptom, treatment phase and evidence quality.

Intervention	Active treatment	After treatment
Mindfulness-based interventions	Recommended for selected anxiety and depression outcomes.	Recommended for selected outcomes.
Yoga	Recommended for selected anxiety and depression outcomes.	Recommended for selected outcomes.
Relaxation therapy	Recommended for selected outcomes.	Evidence varies.
Music therapy	Recommended for selected outcomes.	Evidence varies.
Reflexology	Recommended for selected anxiety and depression outcomes.	Recommended for selected anxiety outcomes.
Acupuncture	Not a general recommendation for all psychological symptoms.	May be considered for selected anxiety outcomes.
Tai chi and qigong	Not a general recommendation for all outcomes during treatment.	Recommended for selected anxiety and depression outcomes.

SIO–ASCO: Integrative Oncology Care of Anxiety and Depression in Adults With Cancer →

When specialist psychological care is needed

Persistent depression, severe anxiety, panic, disabling distress or thoughts of self-harm require appropriate mental health assessment.

Psychological support should not be replaced by advice to think positively, meditate more or simply accept the diagnosis.

12. Palliative Care: Improving Quality of Life Throughout Cancer

Palliative care is an essential part of modern oncology. Its purpose is to prevent and relieve suffering while improving quality of life for patients and their families.

It addresses physical symptoms, psychological distress, social circumstances, communication, decision-making and spiritual needs.

Palliative care is not the same as giving up treatment

One of the most persistent misunderstandings is that palliative care means cancer treatment has stopped or that death is imminent.

In reality, palliative care can be introduced early and delivered alongside active cancer treatment.

A patient receiving chemotherapy, immunotherapy, targeted therapy or radiotherapy can also receive palliative care.

What does palliative care address?

Physical Symptoms

Pain, nausea, vomiting, breathlessness, fatigue, constipation, insomnia and other treatment-related symptoms.

Psychological Health

Anxiety, depression, adjustment, uncertainty and emotional distress.

Social Support

Family responsibilities, caregiver needs, financial pressures and practical support.

Communication and Goals

Treatment decisions, prognosis discussions, advance care planning and patient preferences.

What the 2024 ASCO guideline recommends

The ASCO Palliative Care for Patients With Cancer guideline update recommends early referral of patients with advanced solid tumors and hematologic malignancies to specialized interdisciplinary palliative care teams.

These services should be provided in outpatient and inpatient settings, alongside active cancer treatment.

Early specialist involvement is particularly important when patients have uncontrolled symptoms, psychological distress or quality-of-life concerns.

Caregiver support is also part of comprehensive palliative oncology.

ASCO: Palliative Care for Patients With Cancer – Guideline Update (2024) →

When should palliative care be introduced?

It should not be postponed until all anticancer treatments have been exhausted.

Referral may be appropriate when:

There is an advanced or metastatic cancer diagnosis.
Pain or other symptoms are difficult to control.
Repeated emergency visits or hospitalizations occur.
The patient experiences substantial functional decline.
There are complex treatment decisions.
Psychosocial or spiritual needs remain unmet.
Caregivers require additional support.

Palliative care versus hospice care

Palliative care can be provided at any stage of serious illness. Hospice is a more specific model of comfort-focused care for people meeting the applicable clinical and regulatory eligibility criteria, generally near the end of life.

The availability and eligibility rules differ between countries and healthcare systems.

End-of-life symptom management

When cancer progresses despite treatment, symptom management remains active medical care.

Priority may shift towards:

Comfort and pain relief.
Breathlessness management.
Nausea and vomiting control.
Anxiety and agitation relief.
Management of secretions and other distressing symptoms.
Family support and communication.
Respect for the patient's values and preferences.

The goal is to minimize suffering and protect dignity, not to impose unnecessary treatments or unrealistic expectations.

13. Complementary Therapies: What Is Supported by Evidence?

Complementary interventions can have a role in symptom management, but their evidence varies substantially by symptom and treatment setting.

A therapy shown to help one symptom cannot automatically be assumed to work for another.

Evidence overview

Intervention	Symptom area	Evidence interpretation
Exercise	Fatigue, physical function and strength.	Guideline-supported.
CBT	Fatigue, insomnia, anxiety and depression.	Guideline-supported for defined indications.
Mindfulness	Fatigue, anxiety and depression.	Guideline-supported for selected outcomes.
Acupuncture	Aromatase inhibitor joint pain, selected general pain and vasomotor symptoms.	Indication-specific evidence.
Acupressure	Selected pain and post-treatment fatigue.	Conditional and setting-specific evidence.
Hypnosis	Procedural pain, anxiety and selected symptoms.	Guideline-supported for specific situations.
Massage	Pain in selected palliative or hospice settings.	Guideline-supported for defined circumstances.
Yoga	Anxiety, depression, quality of life and selected survivor symptoms.	Evidence varies according to indication.
Tai chi and qigong	Fatigue, movement and psychological wellbeing.	Evidence-supported for selected outcomes.
Ginger	Investigated for nausea and vomiting.	Evidence mixed; not a replacement for prescribed antiemetics.
Essential oils	Relaxation and selected anxiety symptoms.	Limited and setting-specific evidence.
Mistletoe	Investigated for quality of life and other oncology outcomes.	Insufficient evidence to establish a general anticancer benefit.

What about supplements for cancer symptoms?

Patients frequently consider magnesium, vitamin B complexes, vitamin D, omega-3, antioxidants, curcumin, ginseng and other nutraceuticals.

However, a product being marketed for fatigue, pain or sleep does not establish clinical efficacy.

For example, the ASCO–SIO fatigue guideline found no benefit from many dietary supplements studied for cancer-related fatigue and specifically did not recommend routine L-carnitine use for this purpose.

Supplements also have potential interactions with chemotherapy, targeted agents, anticoagulants and other medicines.

Review each product with the oncology team or oncology pharmacist before use.

Evidence before marketing claims

Be cautious of clinics and products claiming to treat multiple unrelated cancer symptoms or to improve tumor response through unvalidated protocols.

Symptom relief, quality-of-life improvements and anticancer activity are separate claims that require separate evidence.

14. When to Seek Urgent Medical Attention

Some cancer-related symptoms require immediate or same-day medical review. A supportive-care approach must include recognition of potential emergencies.

Symptom or situation	Why it matters	Recommended response
Fever of 38°C (100.4°F) or higher during chemotherapy	Possible neutropenic fever or serious infection.	Contact the oncology emergency service immediately according to the treatment team's instructions.
Sudden chest pain or severe breathlessness	Possible pulmonary embolism, cardiac event or treatment complication.	Emergency medical assessment.
New back pain with weakness, numbness or bladder/bowel changes	Possible spinal cord or cauda equina compression.	Emergency assessment.
Persistent vomiting or inability to retain fluids	Dehydration, obstruction or metabolic disturbance.	Urgent medical assessment.
Severe or rapidly worsening diarrhea	Dehydration, infection or immune-related colitis.	Contact the oncology team urgently.
Severe abdominal pain and swelling with inability to pass gas or stool	Possible bowel obstruction.	Immediate medical assessment.
New confusion, fainting or severe weakness	Possible infection, electrolyte disorder or other serious complication.	Urgent assessment.
Uncontrolled pain	May indicate progression, fracture, nerve compression or inadequate pain control.	Urgent review by the oncology or palliative care team.
Inability to swallow liquids or significant dehydration	Potential nutritional and fluid compromise.	Prompt medical review.

Patients receiving chemotherapy, immunotherapy or other intensive cancer treatment should know exactly which emergency number to contact, including outside clinic hours.

Do not wait for the next scheduled appointment when serious new symptoms develop.

NCI: Bowel Obstruction and Cancer →

15. The SmartCancer Integrated Symptom Management Pathway

Our approach is to organize symptom management into a consistent clinical sequence.

Step 1: Identify the symptom

Record onset, severity, duration, frequency, associated symptoms and functional impact.

Step 2: Investigate the cause

Determine whether the problem relates to the cancer, treatment, another medical condition, medication or psychological factors.

Step 3: Identify urgent complications

Exclude infection, obstruction, bleeding, severe dehydration, cardiovascular problems and neurological emergencies.

Step 4: Apply established symptom treatment

Use appropriate medical management, medication, procedures and rehabilitation according to current clinical guidance.

Step 5: Add suitable supportive and integrative interventions

Consider CBT, exercise, mindfulness, acupuncture, selected relaxation therapies, nutritional interventions and other complementary approaches where evidence and safety support their use.

Step 6: Monitor the response

Reassess symptom intensity, quality of life, daily function, treatment tolerance and adverse effects.

Step 7: Escalate or change the plan

Refer to specialists in pain medicine, palliative care, psycho-oncology, rehabilitation or other relevant services when symptoms remain inadequately controlled.

Our symptom management framework

Symptom

What is the patient experiencing?

Cause

Why is it happening?

Evidence

Which interventions have demonstrated benefit?

Safety

What complications or interactions must be considered?

Intervention

What is the appropriate integrated care plan?

Outcome

Has comfort, function or quality of life improved?

16. Frequently Asked Questions

What is integrative cancer symptom management?

It combines conventional medical symptom treatment with appropriate supportive and complementary interventions to improve comfort, function and quality of life during cancer and its treatment.

Can complementary therapies replace cancer medications?

No. Acupuncture, mindfulness, massage, exercise and other complementary approaches may help selected symptoms, but should not replace prescribed pain medicines, antiemetics, cancer treatment or other necessary medical care.

What is the best treatment for cancer-related fatigue?

There is no single treatment for every patient. The cause should first be assessed. Exercise, CBT and mindfulness-based programs have guideline support during and after cancer treatment. Other interventions may be appropriate in selected circumstances.

Is acupuncture useful for cancer patients?

Acupuncture may help selected conditions, including aromatase inhibitor-related joint pain and certain cancer pain settings. Its usefulness for other symptoms varies and should not be generalized across all forms of cancer-related discomfort.

Can opioids be used for cancer pain?

Yes. Opioids are an important medical treatment for moderate-to-severe cancer-related pain when appropriate. They require individualized prescribing, follow-up and management of adverse effects, including constipation, nausea and sedation.

What helps chemotherapy-induced nausea?

Guideline-based antiemetic prevention is the foundation. Different chemotherapy regimens require different antiemetic combinations. Nutritional adjustments, appropriate hydration, and selected integrative techniques may provide additional support.

Can chemotherapy-induced neuropathy be reversed?

Some patients improve over time, but neuropathy can persist. Management includes symptom assessment, treatment review, appropriate medication for painful neuropathy and functional rehabilitation. Complete recovery is not guaranteed.

Does vitamin B prevent chemotherapy-induced neuropathy?

No supplement has been established as a universal prevention strategy. High-dose supplements should not be started without reviewing the actual evidence and potential interactions.

What is the best way to treat insomnia in cancer survivors?

CBT-I is the recommended first-line approach for insomnia in cancer survivors under the ESMO guideline. Treatment should also address contributing factors such as pain, hot flashes, anxiety, medication effects and sleep-disordered breathing.

Are hot flashes normal during breast cancer treatment?

They are common, especially with hormonal treatments that reduce estrogen activity. Nonhormonal interventions and selected medicines may help. Drug interactions, particularly between some antidepressants and tamoxifen, must be considered.

Is palliative care only for terminal cancer?

No. Palliative care can be introduced early and delivered alongside active cancer treatment. It addresses symptoms, distress, quality of life, communication and family needs.

When should a cancer patient see a palliative care specialist?

Early referral is appropriate for patients with advanced cancer and particularly those experiencing uncontrolled symptoms, complex treatment decisions or significant psychological and social distress.

Can palliative care improve quality of life?

Specialist palliative care aims to reduce suffering, manage symptoms and support patients and caregivers. It is an important component of comprehensive cancer care.

Should cancer patients use multiple supplements for fatigue and pain?

Not automatically. Many supplements have insufficient evidence for these indications and some can interact with cancer treatments. Individual products should be assessed by a qualified clinician or oncology pharmacist.

17. Clinical Guidelines and Research Library

A. Fatigue

ASCO–SIO: Management of Fatigue in Adult Survivors of Cancer (2024)

B. Cancer Pain

C. Nausea and Vomiting

D. Peripheral Neuropathy

ASCO: Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy

E. Sleep

ESMO: Insomnia in Adult Patients With Cancer (2023)

F. Hot Flashes and Vasomotor Symptoms

G. Gastrointestinal and Oral Complications

H. Anxiety and Depression

SIO–ASCO: Integrative Oncology Care of Anxiety and Depression in Adults With Cancer (2023)

I. Palliative Care

ASCO: Palliative Care for Patients With Cancer – Guideline Update (2024)

J. Related SmartCancer Resources

Our Perspective: Symptom Relief Is an Essential Part of Cancer Care

Medical progress should not be measured only by how effectively a treatment targets a tumor. It should also be measured by how well we help patients live through treatment, maintain independence, preserve dignity and experience the best possible quality of life.

Fatigue should be investigated rather than dismissed. Pain should be treated rather than endured. Nausea should not be accepted as an unavoidable consequence of chemotherapy. Neuropathy, insomnia, hot flashes and gastrointestinal complications deserve proper assessment and management.

Complementary therapies have a role where evidence supports their use, but they should be integrated responsibly with established medical care.

And palliative care should be available when patients need it, not reserved for the final days of life.

The SmartCancer principle

Identify the cause. Relieve the symptom. Preserve function. Protect quality of life. Integrate supportive and complementary care with evidence-based oncology.

Comprehensive cancer care means treating the disease while caring for the person.

Medical Disclaimer

This article is for educational and research purposes only. It does not provide individualized medical advice, diagnosis or treatment recommendations.

Symptoms in patients with cancer may indicate treatment complications, infection, disease progression or other serious conditions. New, severe or worsening symptoms require appropriate medical evaluation.

Complementary approaches are not substitutes for established medical treatment. Prescription medicines, supplements and integrative interventions should be reviewed by the treating oncology team or an appropriately qualified healthcare professional.

Never delay, discontinue or replace cancer treatment on the basis of information presented in this article.

SmartCancer | OneDayMD Research Network
Integrative Oncology · Supportive Oncology · Cancer Symptom Management · Palliative Care
Last updated: November 14, 2026.